ABcann Global Corporation (TSX-V: ABCN) announced on May 23rd the company’s medical cannabis brand named Beacon Medical.  Beacon Medical is ABcann’s solution for patients and healthcare providers who may have a difficult time finding their optimal treatment method.

The Beacon brand was a result from a study conducted on 1,500 Canadians in 2018.  The company used this study’s data to determine patient usage, needs, and general knowledge on medical cannabis.  The product from this study was the creation of the Beacon Medical platform which will focus on patient registration, product information, and purchasing.

ABCN has not had any noticeable increase or decrease to value from this announcement.